Faeth Therapeutics, Inc. (NASDAQ: FTH) reported Q2 EPS of ($2.84), $1.32 better than the analyst estimate of ($4.16).

For earnings history and earnings-related data on Faeth Therapeutics, Inc. (FTH) click here.